Acide tauroursodéoxycholique
L'acide tauroursodéoxycholique (TUDCA) est un dérivé d'acide biliaire utilisé comme supplément alimentaire, connu pour ses avantages potentiels pour la santé du foie et au-delà.
Aperçu de l'Efficacité et des Risques
Condition | Efficacité | Détails |
---|---|---|
Maladie du foie gras | Tauroursodeoxycholic Acid (TUDCA) has been shown in clinical trials to improve liver function and reduce liver fat in patients with fatty liver disease, suggesting a significant therapeutic effect. | |
Résistance à l'insuline | Studies have indicated that TUDCA can improve insulin sensitivity, thereby potentially benefiting conditions associated with insulin resistance. The evidence is supported by both animal and human studies. | |
Stress oxydatif | TUDCA has been demonstrated to reduce oxidative stress in various cellular models, suggesting a protective effect against oxidative damage. This is relevant for overall health and longevity. | |
Inflammation | TUDCA has anti-inflammatory properties, as shown in various studies. It can reduce inflammation in different tissues, which is beneficial for conditions characterized by chronic inflammation. | |
Maladies Neurodégénératives | TUDCA has shown potential in preclinical studies to protect against neurodegenerative diseases by reducing endoplasmic reticulum stress and promoting cellular survival pathways. | |
Dysbiose intestinale | While direct evidence is limited, TUDCA's role in improving bile flow and its anti-inflammatory properties may indirectly support gut health. More research is needed to confirm its effectiveness for gut dysbiosis. | |
Peut causer des troubles gastro-intestinaux. | Le TUDCA peut entraîner des troubles gastro-intestinaux, notamment de la diarrhée ou des nausées, chez certaines personnes. |
Complément Recommandé
Aucune combinaison spécifique trouvée pour Acide tauroursodéoxycholique pour le moment.